On Saturday 17 January, President Donald Trump announced that he would be imposing an extra 10 per cent tariff on Germany, ...

The confident inflationary assertions were likely due to some recency bias. It’s a common view that the Democrats lost the ...

The deal with Siemens Health also transformed the group’s balance sheet and slashed finance costs. Kromek has received $30mn ...

It was German company Döhler’s decisive intervention, by buying a huge stake in Treatt, that caused the recommended bid from ...

Admiral’s cash returns to shareholders have waxed and waned in accordance with the insurance cycle, but it aims to pay out ...

The noise has investors scrambling for cover – gold surged to a fresh record high at $4,725/oz and silver attacked the $95 ...

Alex Newman and Lord Lee are joined by Lawrence Hutchings, in his final interview before his surprise exit from Workspace ...

These numbers are important, given Christmas trading can constitute up to a quarter of pubs’ yearly profit. Analysts at ...

The defence tech company is making progress but still has work to do to ensure it hits its full-year growth target ...

GSK (GSK) has agreed to buy US-listed biotech RAPT Therapeutics (US: RAPT) for $58 a share, valuing the company at about $2.2bn (£1.6bn), as it bolsters its respiratory and immunology pipeline.

They have made decent inroads, with around 21.5mn accounts opened: that’s c40 per cent of the adult population. However, many ...

The threat by Trump risks reigniting a trade war with Europe, with the EU looking at retaliatory tariffs. Quite apart from ...